Descriptive analysis on anthropometric, biochemical, and gynaecological profiles between PCOS cases and controls
Sl No. | Variable | Median (25–75% percentile) controln = 75 | Median (25–75% percentile) PCOSn = 98 | P value |
---|---|---|---|---|
1 | Menarche (year) | 13 (12–15) | 13 (12–15) | 0.71 |
2 | Age (year) | 28 (26–31) | 28 (25–29) | 0.20 |
3 | BMI (kg/m2) | 24 (22–25) | 27 (24–30) | < 0.0001$ |
4 | PRL (ng/mL) | 11 (6.7–17) | 14 (8.8–23) | < 0.05* |
5 | AMH (ng/mL) | 1.8 (1.2–2.1) | 5.1 (3.8–8.6) | < 0.0001$ |
6 | FBS (mg/dL) | 90 (85–93) | 98 (81–105) | 0.031* |
7 | 2-h PG (mg/dL) | 110 (102–121) | 122 (107–145) | 0.0001$ |
8 | Hb (gm/dL) | 12 (12–13) | 12 (10–13) | 0.0003# |
9 | ESR (mm) | 20 (14–24) | 14 (10–20) | 0.07 |
10 | FSH (IU/L) | 5 (3.7–7) | 4.7 (3.5–6.2) | < 0.0001$ |
11 | LH (IU/L) | 4.2 (2.8–6.3) | 6.7 (5.1–8.3) | 0.05* |
12 | LH/FSH | 0.9 (0.5–1.5) | 1.5 (1–2.1) | < 0.0001$ |
13 | TSH (µIU/mL) | 2 (1.6–3.4) | 2.6 (1.9–3.8) | < 0.0001$ |
14 | Progesterone (mol/L) | 0.68 (0.42–1) | 0.84 (0.60–1.3) | 0.038* |
15 | Mg (mg/dL) | 1.9 (1.8–2.2) | 1.8 (1.3–2.3) | 0.03* |
16 | Cp (IU/L) | 1,140 (845–1,483) | 1,420 (945–1,810) | 0.0003# |
17 | AFC (n) | 7 (6.2–8.2) | 13 (11–17) | < 0.0001$ |
18 | No mense in a year | 13 (11–13) | 8.2 (6.3–10) | < 0.0001$ |
Statistical analysis was performed using the GraphPad Prism 6.0. The continuous variables are expressed as mean ± SD; the significant differences obtained in PCOS subjects and controls were calculated and compared using ANOVA. * P value < 0.05 was considered to be statistically significant. Values are expressed * P < 0.05, # P <0.01, and $ P < 0.001. 2-h PG: postload 2-hour glucose; FBS: fasting blood glucose; n: number; PRL: prolactin; Sl No.: serial number